Glucocorticoids for Duchenne Muscular Dystrophy

Abstract

Investigators at the Dubowitz Neuromuscular Centre, Great Ormond Street Hospital, and other centers in the UK, conducted a prospective longitudinal study across 17 neuromuscular centers in the UK of 360 boys aged 3-15 years with Duchenne muscular dystrophy who were treated with daily or intermittent (10 days on/10 days off) prednisolone for a mean duration of 4 years.

Keywords

• duchenne muscular dystrophy
• cushingoid features
• glucocorticoids